Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Development of Novel or Improved Infertility Technologies…

U.S. National Institutes of Health·United States of America

Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional)

Closes 11/20/2025$100k – $1MGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking applications for research to support and facilitate multidisciplinary research approaches for the development or improvement of technologies designed to improve fertility outcomes in patients dealing with infertility, particularly in the context of assisted reproductive technologies (ART). The goal of this notice of funding opportunity (NOFO) is to position innovative and validated technologies for future clinical development. • Eligible applicants include public and state controlled institutions of higher education, private institutions of higher education, for-profit organizations, non-profits, and small businesses. • The estimated funding for this opportunity is $3,300,000. • The application response date is November 20, 2025. • The award date is expected to be July 1, 2026.

Attached files

Contact

Travis Kent(Program Contact)

[email protected]

(301) 435-2295

Key dates

Opened
5/27/2025
Closes
11/20/2025
Projected award
7/1/2026

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
RFA-HD-26-001

Budget estimate

$100,000 – $1,000,000

Based on the estimated funding of $3,300,000, the budget for this opportunity could range from $100,000 to $1,000,000 per year, depending on the number of awards and the duration of the project. The actual budget will depend on the specific proposal and the NIH's funding decisions.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 75%

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

74% match

NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

Closes 12/1/2030Opened 2/27/2026

U.S. National Institutes of Health·United States of America

74% match

Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)

Closes 5/7/2029Opened 9/15/2025

U.S. National Institutes of Health·United States of America

74% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

74% match

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Closes 6/3/2027Opened 7/14/2026

U.S. National Institutes of Health·United States of America

74% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026

U.S. National Institutes of Health·United States of America

73% match

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Closes 11/10/2026Opened 9/8/2025

U.S. National Institutes of Health·United States of America

73% match

Discovery Gateway to Reproductive Health Innovation

Closes 9/30/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

72% match

NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

Closes 11/16/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

72% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

72% match

Technology Development Program

Closes 2/4/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

72% match

INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)

Closes 6/15/2028Opened 9/25/2025

U.S. National Institutes of Health·United States of America

71% match

National Biomedical Research Centers (P50 Clinical Trial Optional)

Closes 1/24/2027Opened 5/12/2026

U.S. National Institutes of Health·United States of America

71% match

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029Opened 1/26/2026

U.S. National Institutes of Health·United States of America

71% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

71% match

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Closes 6/2/2027Opened 6/17/2024

U.S. National Institutes of Health·United States of America

71% match

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 4/9/2026

U.S. National Institutes of Health·United States of America

71% match

Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

Closes 7/5/2029Opened 9/9/2025

U.S. National Institutes of Health·United States of America

71% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

71% match

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Closes 1/28/2027Opened 2/23/2024

U.S. National Institutes of Health·United States of America

71% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

71% match

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

71% match

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Closes 7/2/2027Opened 7/5/2023

U.S. National Institutes of Health·United States of America

71% match

Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed)

Closes 2/15/2028Opened 9/16/2026

U.S. National Institutes of Health·United States of America

70% match

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Closes 11/13/2026Opened 2/1/2024